Limitations of the national cancer data base to evaluate early-stage anal cancer treatment outcomes.
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, ManchesterIssue Date
2018-04-25
Metadata
Show full item recordCitation
Limitations of the national cancer data base to evaluate early-stage anal cancer treatment outcomes. 2018 JAMA SurgJournal
JAMA SurgeryDOI
10.1001/jamasurg.2018.0394PubMed ID
29710110Type
ArticleLanguage
enISSN
2168-6262ae974a485f413a2113503eed53cd6c53
10.1001/jamasurg.2018.0394
Scopus Count
Collections
Related articles
- Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes.
- Authors: Leeds IL, Fang SH
- Issue date: 2018 Jul 1
- Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes-Reply.
- Authors: Chai CY, Tran Cao HS, Massarweh NN
- Issue date: 2018 Jul 1
- Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
- Authors: Malakhov N, Kavi AM, Lee A, Adedoyin P, Sheth N, Lederman AJ, Schreiber D
- Issue date: 2019 Dec
- Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
- Authors: Amini A, Jones BL, Ghosh D, Schefter TE, Goodman KA
- Issue date: 2017 Jan 1
- [A case of long-term survival in stage IV squamous cell carcinoma of the anal canal with multidisciplinary treatment].
- Authors: Ogawa S, Fujishiro H, Fujiwara A, Tsukano K, Kotani S, Yamanouchi S, Kusunoki R, Aimi M, Miyaoka Y, Kohge N, Onuma H
- Issue date: 2017